Transplacental lung carcinogenesis: Molecular mechanisms and pathogenesis

Toxicology and Applied Pharmacology

Volumn 198, Issue 2, 2004, Pages 95-110

  Miller, Mark Steven ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

4 aminobiphenyl; ABP; AHH; AhR; allele specific oligonucleotide hybridization; aryl hydrocarbon hydroxylase; aryl hydrocarbon receptor; ASO; BP; Fetus; Lung cancer; Metabolism; Molecular pathogenesis; Oncogenes; Transplacental carcinogenesis; Tumor suppressor genes

Indexed keywords

CARCINOGEN; POLYCYCLIC AROMATIC HYDROCARBON;

BLOOD PLACENTA BARRIER; DISEASE PREDISPOSITION; DNA DAMAGE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EXPERIMENTAL MODEL; EXPERIMENTATION; GENE EXPRESSION; GENE INTERACTION; GESTATIONAL AGE; HUMAN; LUNG CARCINOGENESIS; METABOLISM; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MUTATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRENATAL EXPOSURE; REVIEW; TOXICITY; TRANSPLACENTAL CARCINOGENESIS;

ANIMALS; CARCINOGENS; DNA; FEMALE; HUMANS; LUNG NEOPLASMS; MATERNAL-FETAL EXCHANGE; PREGNANCY;

ANIMALIA;

EID: 3242660052     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.07.018     Document Type: Review

References (174)

1. Alberg A.J., Samet J.M. Epidemiology of lung cancer. Kane M.A., Bunn P.A. Jr. Biology of Lung Cancer. 1998;11-51 Marcel Dekker, New York
2. Alexander F.E., Patheal S.L., Biondi A., Brandalise S., Cabrera M.E., Chan L.C., Chen Z., Cimino G., Cordoba J.C., Gu L.J., Hussein H., Ishii E., Kamel A.M., Labra S., Magalhaes I.Q., Mizutani S., Petridou E., de Oliveira M.P., Yuen P., Wiemels J.L., Greaves M.F. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 61:2001;2542-2546
3. Anderson L.M., Jones A.B., Riggs C.W., Ohshima M. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis. 6:1985;1389-1393
4. Anderson L.M., Jones A.B., Miller M.S., Chauhan D.P. Metabolism of transplacental carcinogens. Napalkov N.P., Rice J.M., Tomatis L., Yamasaki H. Transplacental and Multigeneration Carcinogenesis. 1989;155-188 IARC Scientific Publications, Lyon, France
5. Anderson L.M., Diwan B.A., Fear N.T., Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108(Suppl. 3):2000;573-594
6. Autrup H. Transplacental transfer of genotoxins and transplacental carcinogenesis. Environ. Health Perspect. 101(Suppl. 2):1993;33-38
7. Bailey-Wilson J.E., Wiest J.S., Saccomanno G., Anderson M.W. Genetics of lung cancer. Kane M.A., Bunn P.A. Jr. Biology of Lung Cancer. 1998;53-98 Marcel Dekker, New York
8. Ballestar E., Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis. 23:2002;1103-1109
9. INK4a genes in the development of mouse lung tumors. Exp. Lung Res. 24:1998;463-479
10. Belinsky S.A., Swafford D.S., Middleton S.K., Kennedy C.H., Tesfaigzi J. Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis. 18:1997;115-120
11. Bigger C.A., Sawicki J.T., Blake D.M., Raymond L.G., Dipple A. Products of binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse skin. Cancer Res. 43:1983;5647-5651
12. Birnbaum L.S., Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111:2003;389-394
13. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-248
14. Boffetta P., Tredaniel J., Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ. Health Perspect. 108:2000;73-82
15. Bolognesi C., Rossi L., Barbieri O., Santi L. Benzo[a]pyrene-induced DNA damage in mouse fetal tissues. Carcinogenesis. 6:1985;1091-1095
16. Branstetter D.G., Stoner G.D., Budd C., Conran P.B., Goldblatt P.J. Effect of gestational development of lung tumor size and morphology in the mouse. Cancer Res. 48:1988;379-386
17. Branstetter D.G., Stoner G.D., Budd C., Conran P.B., Goldblatt P.J. Relationship between in utero development of the mouse liver and tumor development following transplacental exposure to ethylnitrosourea. Cancer Res. 49:1989;3620-3626
18. Bunin G.R., Kramer S., Marrero O., Meadows A.T. Gestational risk factors for Wilms' tumor: results of a case-control study. Cancer Res. 47:1987;2972-2977
19. Bunin G.R., Kuijten R.R., Buckley J.D., Rorke L.B., Meadows A.T. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. New Engl. J. Med. 329:1993;536-541
20. Burki K., Liebelt A.G., Bresnick E. Expression of aryl hydrocarbon hydroxylase induction in mouse tissues in vivo and in organ culture. Arch. Biochem. Biophys. 158:1973;641-649
21. Burki K., Liebelt A.G., Bresnick E. Induction of aryl hydrocarbon hydroxylase in mouse tissues from a high and low cancer strain and their F 1 hybrids. J. Natl. Cancer Inst. 50:1973;369-380
22. Cantley L.C., Auger K.R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 64:1991;281-302
23. Carbone D.P., Minna J.D. The molecular genetics of lung cancer. Adv. Intern. Med. 37:1992;153-171
24. Chang C., Smith D.R., Prasad V.S., Sidman C.L., Nebert D.W., Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics. 3:1993;312-321
25. Chauhan D.P., Miller M.S., Owens I.S., Anderson L.M. Gene expression, ontogeny and transplacental induction of hepatic UDP-glucuronosyl transferase activity in mice. Dev. Pharmacol. Ther. 16:1991;139-149
26. Coghlin J., Gann P.H., Hammond S.K., Skipper P.L., Taghizadeh K., Paul M., Tannenbaum S.R. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. J. Natl. Cancer Inst. 83:1991;274-280
27. Conti C.J. Mutations of genes of the ras family in human and experimental tumors. Klein-Szanto A.J.P., Anderson M.W., Barrett J.C., Slaga T.J. Comparative Molecular Carcinogenesis. 1992;357-378 Wiley-Liss, New York
28. Correa P., Pickle L.W., Fontham E., Lin Y., Haenszel W. Passive smoking and lung cancer. Lancet. 2:1983;595-597
29. Coughtrie M.W., Burchell B., Leakey J.E., Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol. 34:1988;729-735
30. Dey A., Westphal H., Nebert D.W. Cell-specific induction of mouse Cyp1a1 mRNA during development. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7446-7450
31. Di Ilio C., Tiboni G.M., Sacchetta P., Angelucci S., Bucciarelli T., Bellati U., Aceto A. Time-dependent and tissue-specific variations of glutathione transferase activity during gestation in the mouse. Mech. Ageing Dev. 78:1995;47-62
32. Doll R., Wakeford R. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 70:1997;130-139
33. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221
34. Dragani T.A., Manenti G., Pierotti M.A. Genetics of murine lung tumors. Adv. Cancer Res. 67:1995;83-112
35. Dutton G.J. Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu. Rev. Pharmacol. Toxicol. 18:1978;17-35
36. Fan J., Bertino J.R. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene. 14:1997;2595-2607
37. Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J., Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 21:2002;2593-2604
38. Feychting M., Plato N., Nise G., Ahlbom A. Paternal occupational exposures and childhood cancer. Environ. Health Perspect. 109:2001;193-196
39. Finette B.A., O'Neill J.P., Vacek P.M., Albertini R.J. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat. Med. 4:1998;1144-1151
40. Fisher G.H., Wellen S.L., Klimstra D., Lenczowski J.M., Tichelaar J.W., Lizak M.J., Whitsett J.A., Koretsky A., Varmus H.E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15:2001;3249-3262
41. Floyd H.S., Tichelaar J.W., Dance S.T., Everitt J., Whitsett J.A., Miller M.S. Expression of mutant human Ki-ras induces lung tumors in bitransgenic mice. Toxicol. Sci. 72(1-S):2003;413
42. Foiles P.G., Miglietta L.M., Akerkar S.A., Everson R.B., Hecht S.S. Detection of O6-methyldeoxyguanosine in human placental DNA. Cancer Res. 48:1988;4184-4188
43. Gallagher E.P., Gardner J.L. Comparative expression of two alpha class glutathione S-transferases in human adult and prenatal liver tissues. Biochem. Pharmacol. 63:2002;2025-2036
44. Gazzeri S., Gouyer V., Vour'ch C., Brambilla C., Brambilla E. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene. 16:1998;497-504
45. George J.D., Manson J.M. Strain-dependent differences in the metabolism of 3-methylcholanthrene by maternal, placental, and fetal tissues of C57BL/6J and DBA/2J mice. Cancer Res. 46:1986;5671-5675
46. Georges R.N., Mukhopadhyay T., Zhang Y., Yen N., Roth J.A. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res. 53:1993;1743-1746
47. Geradts J., Kratzke R.A., Niehans G.A., Lincoln C.E. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res. 55:1995;6006-6011
48. Gielen J.E., Goujon F.M., Nebert D.W. Genetic regulation of aryl hydrocarbon hydroxylase induction: II. Simple Mendelian expression in mouse tissues in vivo. J. Biol. Chem. 247:1972;1125-1137
49. Gold E.B., Leviton A., Lopez R., Gilles F.H., Hedley-Whyte E.T., Kolonel L.N., Lyon J.L., Swanson G.M., Weiss N.S., West D. Parental smoking and risk of childhood brain tumors. Am. J. Epidemiol. 137:1993;620-628
50. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40:1988;243-288
51. Gonzalez-Zulueta M., Bender C.M., Yang A.S., Nguyen T., Beart R.W., van Tornout J.M., Jones P.A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55:1995;4531-4535
52. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878
53. Gressani K.M., Rollins L.A., Leone-Kabler S.L., Cline J.M., Miller M.S. Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis. 19:1998;1045-1052
54. Gressani K.M., Leone-Kabler S.L., O'Sullivan M.G., Case L.D., Malkinson A.M., Miller M.S. Strain-specific lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis. 20:1999;2159-2165
55. Gressani K.M., Leone-Kabler S., O'Sullivan M.G., Townsend A.J., Miller M.S. Prenatal toxicity and lack of carcinogenicity of 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ) following transplacental exposure. Toxicol. Sci. 55:2000;407-414
56. Guenthner T.M., Nebert D.W. Evidence in rat and mouse liver for temporal control of two forms of cytochrome P-450 inducible by 2,3,7,8- tetrachlorodibenzo-p-dioxin. Eur. J. Biochem. 91:1978;449-456
57. Hainaut P., Hernandez-Boussard T.M. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ. Health Perspect. 106:1998;385-391
58. Hansen C., Sorensen L.D., Asmussen I., Autrup H. Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratog., Carcinog., Mutagen. 12:1992;51-60
59. Harada K., Toyooka S., Maitra A., Maruyama R., Toyooka K.O., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Minna J.D., Gazdar A.F. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene. 21:2002;4345-4349
60. Harada K., Toyooka S., Shivapurkar N., Maitra A., Reddy J.L., Matta H., Miyajima K., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Chaudhary P.M., Gazdar A.F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res. 62:2002;5897-5901
61. Hatch M.C., Warburton D., Santella R.M. Polycyclic aromatic hydrocarbon-DNA adducts in spontaneously aborted fetal tissue. Carcinogenesis. 11:1990;1673-1675
62. Hegi M.E., Soderkvist P., Foley J.F., Schoonhoven R., Swenberg J.A., Kari F., Maronpot R., Anderson M.W., Wiseman R.W. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis. 14:1993;803-810
63. Hegi M.E., Devereux T.R., Dietrich W.F., Cochran C.J., Lander E.S., Foley J.F., Maronpot R.R., Anderson M.W., Wiseman R.W. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res. 54:1994;6257-6264
64. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D., Baylin S.B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530
65. Herzog C.R., Soloff E.V., McDoniels A.L., Tyson F.L., Malkinson A.M., Haugen-Strano A., Wiseman R.W., Anderson M.W., You M. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-α and p16INK4a-β in mouse lung tumor cells. Oncogene. 13:1996;1885-1891
66. Hines R.N., McCarver D.G. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J. Pharmacol. Exp. Ther. 300:2002;355-360
67. Horio Y., Chen A., Rice P., Roth J.A., Malkinson A.M., Schrump D.S. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol. Carcinog. 17:1996;217-223
68. Idle J.R. Is environmental carcinogenesis modulated by host polymorphism? Mutat. Res. 247:1991;259-266
69. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:2001;3243-3248
70. Jaiswal A.K., Gonzalez F.J., Nebert D.W. Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res. 13:1985;4503-4520
71. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun A.J. Cancer statistics. CA Cancer J. Clin. 53:2003;5-26
72. John E.M., Savitz D.A., Sandler D.P. Prenatal exposure to parents' smoking and childhood cancer. Am. J. Epidemiol. 133:1991;123-132
73. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 410:2001;1111-1116
74. Juchau M.R. Bioactivation in chemical teratogenesis. Annu. Rev. Pharmacol. Toxicol. 29:1989;165-187
75. Kamb A. Cell-cycle regulators and cancer. Trends Genet. 11:1995;136-140
76. Kaneko Y., Homma C., Maseki N., Sakurai M., Hata J. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res. 51:1991;5937-5942
77. Keohavong P., DeMichele M.A., Melacrinos A.C., Landreneau R.J., Weyant R.J., Siegfried J.M. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin. Cancer Res. 2:1996;411-418
78. Kimura S., Gonzalez F.J., Nebert D.W. The murine Ah locus. Comparison of the complete cytochrome P1-450 and P3-450 cDNA nucleotide and amino acid sequences. J. Biol. Chem. 259:1984;10705-10713
79. Krajinovic M., Labuda D., Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics. 12:2002;655-658
80. Kratzke R.A., Greatens T.M., Rubins J.B., Maddaus M.A., Niewoehner D.E., Niehans G.A., Geradts J. Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res. 56:1996;3415-3420
81. Lackmann G.M., Salzberger U., Tollner U., Chen M., Carmella S.G., Hecht S.S. Metabolites of a tobacco-specific carcinogen in urine from newborns. J. Natl. Cancer Inst. 91:1999;459-465
82. Lahdetie J., Engstrom K., Husgafvel-Pursiainen K., Nylund L., Vainio H., Sorsa M. Maternal smoking induced cotinine levels and genotoxicity in second trimester amniotic fluid. Mutat. Res. 300:1993;37-43
83. Legraverend C., Guenthner T.M., Nebert D.W. Importance of the route of administration for genetic differences in benzo[a]pyrene-induced in utero toxicity and teratogenicity. Teratology. 29:1984;35-47
84. Leone-Kabler S.L., Wessner L.L., McEntee M.F., D'Agostino R.B., Miller M.S. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis. 18:1997;1163-1168
85. Linnoila I. Topography of preneoplasia: morphology and markers. Kane M.A., Bunn P.A. Jr. Biology of Lung Cancer. 1998;503-527 Marcel Dekker, New York
86. Loeb L.A., Ernster V.L., Warner K.E., Abbotts J., Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 44:1984;5940-5958
87. Loktionov A., Hollstein M., Martel N., Galendo D., Cabral J.R., Tomatis L., Yamasaki H. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Mol. Carcinog. 3:1990;134-140
88. Lowy D.R., Willumsen B.M. Function and regulation of ras. Annu. Rev. Biochem. 62:1993;851-891
89. Lu L.J., Wang M.Y. Modulation of benzo[a]pyrene-induced covalent DNA modifications in adult and fetal mouse tissues by gestation stage. Carcinogenesis. 11:1990;1367-1372
90. Lu L.J., Harvey R.G., Lee H., Baxter J.R., Anderson L.M. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA. Cancer Res. 50:1990;4239-4247
91. Lumniczky K., Antal S., Unger E., Wunderlich L., Hidvegi E.J., Safrany G. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation. Mol. Carcinog. 21:1998;100-110
92. Ma X., Buffler P.A., Gunier R.B., Dahl G., Smith M.T., Reinier K., Reynolds P. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ. Health Perspect. 110:2002;955-960
93. Mabry M. Activating oncogenes in lung cancer. Kane M.A., Bunn P.A. Jr. Biology of Lung Cancer. 1998;391-412 Marcel Dekker, New York
94. Malkinson A.M. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 54:1989;241-271
95. Malkinson A.M. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res. 52:1992;2670s-2676s
96. Malkinson A.M. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res. 24:1998;541-555
97. Malkinson A.M., Dwyer-Nield L.D., Rice P.L., Dinsdale D. Mouse lung epithelial cell lines - Tools for the study of differentiation and the neoplastic phenotype. Toxicology. 123:1997;53-100
98. Manchester D.K., Jacoby E.H. Sensitivity of human placental monooxygenase activity to maternal smoking. Clin. Pharmacol. Ther. 30:1981;687-692
99. Manchester D.K., Weston A., Choi J.S., Trivers G.E., Fennessey P.V., Quintana E., Farmer P.B., Mann D.L., Harris C.C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9243-9247
100. Manchester D.K., Bowman E.D., Parker N.B., Caporaso N.E., Weston A. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Cancer Res. 52:1992;1499-1503
101. McCarver D.G., Hines R.N. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J. Pharmacol. Exp. Ther. 300:2002;361-366
102. McQueen C.A., Mitchell M.K., Dang L.N., Chau B., Tjalkens R.B., Philbert M.A. Prenatal expression of N-acetyltransferases in C57Bl/6 mice. Chem. Biol. Interact. 145:2003;77-87
103. Meuwissen R., Linn S.C., van d V., Mooi W.J., Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene. 20:2001;6551-6558
104. Miller M.S. Transplacental lung carcinogenesis: a pharmacogenetic mouse model for the modulatory role of cytochrome P450 1A1 on lung cancer initiation. Chem. Res. Toxicol. 7:1994;471-481
105. Miller M.S. Tumor suppressor genes in rodent lung carcinogenesis - mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis. Toxicol. Appl. Pharmacol. 156:1999;70-77
106. Miller M.S., Jones A.B., Chauhan D.P., Park S.S., Anderson L.M. Differential induction of fetal mouse liver and lung cytochromes P-450 by beta-naphthoflavone and 3-methylcholanthrene. Carcinogenesis. 10:1989;875-891
107. Miller M.S., Jones A.B., Chauhan D.P., Anderson L.M. Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Carcinogenesis. 11:1990;1979-1984
108. Miller M.S., Jones A.B., Park S.S., Anderson L.M. The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P450IA1 by the carcinogen in fetal but not adult mice. Toxicol. Appl. Pharmacol. 104:1990;235-245
109. Miller M.S., Juchau M.R., Guengerich F.P., Nebert D.W., Raucy J.L. Drug metabolic enzymes in developmental toxicology. Fundam. Appl. Toxicol. 34:1996;165-175
110. Miller M.S., Leone-Kabler S.L., Rollins L.A., Wessner L.L., Fan M., Schaeffer D.O., McEntee M.F., O'Sullivan M.G. Molecular pathogenesis of transplacentally-induced mouse lung tumors. Exp. Lung Res. 24:1998;557-577
111. Miller M.S., Gressani K.M., Leone-Kabler S., Townsend A.J., Malkinson A.M., O'Sullivan M.G. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters. Exp. Lung Res. 26:2000;709-730
112. Mills N.E., Fishman C.L., Rom W.N., Dubin N., Jacobson D.R. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55:1995;1444-1447
113. Minna J.D., Pass H., Gladstein E., Ihde D. Etiology of lung cancer. DeVita V.T., Hellman S., Rosenberg S.A. Cancer Principles and Practice of Oncology. 1988;593-600 Lippincott, Philadelphia
114. Mitchell D.L., Hartman P.S. The regulation of DNA repair during development. BioEssays. 12:1990;74-79
115. Mitsudomi T., Viallet J., Mulshine J.L., Linnoila R.I., Minna J.D., Gazdar A.F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene. 6:1991;1353-1362
116. Mizesko M.C., Grewe C., Grabner A., Miller M.S. Alterations at the Ink4a locus in transplacentally induced murine lung tumors. Cancer Lett. 172:2001;59-66
117. Mori C., Komiyama M., Adachi T., Sakurai K., Nishimura D., Takashima K., Todaka E. Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses. EHP. Toxicogenomics. 111:2003;7-13
118. Mukhopadhyay T., Tainsky M., Cavender A.C., Roth J.A. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res. 51:1991;1744-1748
119. Nakagawa K., Conrad N.K., Williams J.P., Johnson B.E., Kelley M.J. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene. 11:1995;1843-1851
120. Nebert D.W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20:1989;153-174
121. Nebert D.W., Gelboin H.V. The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch. Biochem. Biophys. 134:1969;76-89
122. Nebert D.W., Gielen J.E. Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. Fed. Proc. 31:1972;1315-1325
123. Neubert D., Tapken S. Prenatal induction of benzo(a)pyrene hydroxylases in mice. Arch. Toxicol. 62:1988;192-199
124. Oda H., Zhang S., Tsurutani N., Shimizu S., Nakatsuru Y., Aizawa S., Ishikawa T. Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res. 57:1997;646-650
125. Okamoto A., Demetrick D.J., Spillare E.A., Hagiwara K., Hussain S.P., Bennett W.P., Forrester K., Gerwin B., Serrano M., Beach D.H., Harris C.C. Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11045-11049
126. Okamoto A., Hussain S.P., Hagiwara K., Spillare E.A., Rusin M.R., Demetrick D.J., Serrano M., Hannon G.J., Shiseki M., Zariwala M. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1995;1448-1451
127. Okey A.B., Vella L.M., Harper P.A. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Mol. Pharmacol. 35:1989;823-830
128. Olshan A.F., Breslow N.E., Daling J.R., Falletta J.M., Grufferman S., Robison L.L., Waskerwitz M., Hammond G.D. Wilms' tumor and paternal occupation. Cancer Res. 50:1990;3212-3217
129. Otterson G.A., Kratzke R.A., Coxon A., Kim Y.W., Kaye F.J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene. 9:1994;3375-3378
130. Otterson G.A., Khleif S.N., Chen W., Coxon A.B., Kaye F.J. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene. 11:1995;1211-1216
131. Perera F.P., Mooney L.A., Dickey C.P., Santella R.M., Bell D., Blaner W., Tang D., Whyatt R.M. Molecular epidemiology in environmental carcinogenesis. Environ. Health Perspect. 104(Suppl. 3):1996;441-443
132. Perera F., Hemminki K., Jedrychowski W., Whyatt R., Campbell U., Hsu Y., Santella R., Albertini R., O'Neill J.P. In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol., Biomarkers Prev. 11:2002;1134-1137
133. Perl A.K., Wert S.E., Nagy A., Lobe C.G., Whitsett J.A. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10482-10487
134. Petersen D.D., McKinney C.E., Ikeya K., Smith H.H., Bale A.E., McBride O.W., Nebert D.W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am. J. Hum. Genet. 48:1991;720-725
135. Preston-Martin S., Correa P. Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv. 8:1989;459-473
136. Preston-Martin S., Yu M.C., Benton B., Henderson B.E. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res. 42:1982;5240-5245
137. Purdie C.A., Harrison D.J., Peter A., Dobbie L., White S., Howie S.E., Salter D.M., Bird C.C., Wyllie A.H., Hooper M.L., Clarke A.R. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene. 9:1994;603-609
138. Randerath E., Avitts T.A., Reddy M.V., Miller R.H., Everson R.B., Randerath K. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin. Cancer Res. 46:1986;5869-5877
139. Raucy J.L., Carpenter S.J. The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods. 29:1993;121-128
140. Re F.C., Manenti G., Borrello M.G., Colombo M.P., Fisher J.H., Pierotti M.A., Della Porta G., Dragani T.A. Multiple molecular alterations in mouse lung tumors. Mol. Carcinog. 5:1992;155-160
141. Reynolds S.H., Anna C.K., Brown K.C., Wiest J.S., Beattie E.J., Pero R.W., Iglehart J.D., Anderson M.W. Activated protooncogenes in human lung tumors from smokers. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1085-1089
142. Reynolds S.H., Wiest J.S., Devereux T.R., Anderson M.W., You M. Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors. Klein-Szanto A.J.P., Anderson M.W., Barrett J.C., Slaga T.J. Comparative Molecular Carcinogenesis. 1992;303-320 Wiley-Liss, New York
143. Rice J.M. Perinatal period and pregnancy: intervals of high risk for chemical carcinogens. Environ. Health Perspect. 29:1979;23-27
144. Robertson K.D. DNA methylation and chromatin - Unraveling the tangled web. Oncogene. 21:2002;5361-5379
145. Rodenhuis S., van de Wetering M.L., Mooi W.J., Evers S.G., van Zandwijk N., Bos J.L. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. New Engl. J. Med. 317:1987;929-935
146. Rodenhuis S., Slebos R.J., Boot A.J., Evers S.G., Mooi W.J., van Wagenaar S.S., Bodegom P.C., Bos J.L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 48:1988;5738-5741
147. Rollins L.A., Leone-Kabler S.L., O'Sullivan M.G., Miller M.S. Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol. Carcinog. 21:1998;177-184
148. Sabourin C.L.K., Wang Q.S., Ralston S.L., Evans J., Coate J., Herzog C.R., Jones S.L., Weghorst C.M., Kelloff G.J., Lubet R.A., You M., Stoner G.D. Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced mouse lung tumors. Exp. Lung Res. 24:1998;499-521
149. Sandler D.P., Everson R.B., Wilcox A.J., Browder J.P. Cancer risk in adulthood from early life exposure to parents' smoking. Am. J. Public Health. 75:1985;487-492
150. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
151. Shapiro G.I., Edwards C.D., Kobzik L., Godleski J., Richards W., Sugarbaker D.J., Rollins B.J. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55:1995;505-509
152. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
153. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163
154. Slebos R.J., Hruban R.H., Dalesio O., Mooi W.J., Offerhaus G.J., Rodenhuis S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cancer Inst. 83:1991;1024-1027
155. Snow E.T. The role of DNA repair in development. Reprod. Toxicol. 11:1997;353-365
156. Steffensen I.L., Schut H.A., Paulsen J.E., Andreassen A., Alexander J. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res. 61:2001;8689-8696
157. Stjernfeldt M., Berglund K., Lindsten J., Ludvigsson J. Maternal smoking during pregnancy and risk of childhood cancer. Lancet. 1:1986;1350-1352
158. Stjernfeldt M., Berglund K., Lindsten J., Ludvigsson J. Maternal smoking and irradiation during pregnancy as risk factors for child leukemia. Cancer Detect. Prev. 16:1992;129-135
159. Strick R., Strissel P.L., Borgers S., Smith S.L., Rowley J.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4790-4795
160. Sukumar S., Barbacid M. Specific patterns of oncogene activation in transplacentally induced tumors. Proc. Natl. Acad. Sci. U.S.A. 87:1990;718-722
161. Takayasu H., Horie H., Hiyama E., Matsunaga T., Hayashi Y., Watanabe Y., Suita S., Kaneko M., Sasaki F., Hashizume K., Ozaki T., Furuuchi K., Tada M., Ohnuma N., Nakagawara A. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin. Cancer Res. 7:2001;901-908
162. Thomas P.E., Kouri R.E., Hutton J.J. The genetics of aryl hydrocarbon hydroxylase induction in mice: a single gene difference between C57BL-6J and DBA-2J. Biochem. Genet. 6:1972;157-168
163. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., Spitz M.R. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl. Cancer Inst. 92:2000;1764-1772
164. Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49:1989;3713-3721
165. Wessner L.L., Fan M., Schaeffer D.O., McEntee M.F., Miller M.S. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis. 17:1996;1519-1526
166. Wheeler C.W., Park S.S., Guenthner T.M. Immunochemical analysis of a
167. Whyatt R.M., Bell D.A., Jedrychowski W., Santella R.M., Garte S.J., Cosma G., Manchester D.K., Young T.-L., Cooper G.M., Ottman R., Perera F.P. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis. 19:1998;1389-1392
168. Whyatt R.M., Perera F.P., Jedrychowski W., Santella R.M., Garte S., Bell D.A. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol., Biomarkers Prev. 9:2000;207-212
169. Whyatt R.M., Jedrychowski W., Hemminki K., Santella R.M., Tsai W.Y., Yang K., Perera F.P. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol., Biomarkers Prev. 10:2001;581-588
170. Wiseman R.W., Cochran C., Dietrich W., Lander E.S., Soderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3759-3763
171. Witschi H. Modulation of lung tumor development in rats, hamsters and mice. Prog. Exp. Tumor Res. 33:1991;132-153
172. b allele following transplacental exposure to 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 72:1984;417-426
173. d allele following in utero exposure to 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 72:1984;427-439
174. Yoshioka M., O'Neill J.P., Vacek P.M., Finette B.A. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions. Cancer Res. 61:2001;3432-3438